Vorinostat and activities of daily living impaired Patient Reports February 12, 2012

Vorinostat Side Effects Report #5378067-6
Vorinostat side effect was reported by a Physician from UNITED STATES on June 22, 2007. Male patient, 55 years of age, weighting 231.0 lb, was diagnosed with multiple myeloma  and was treated with Vorinostat. After drug was administered, patient experienced the following side effects: activities of daily living impaired, neuropathy peripheral. Vorinostat dosage: 400 MG/DAILY/PO. During the same period patient was treated with VELCADE, CENTRUM, FOSAMAX, VALTREX, VITAMIN B CAP. Patient recovered.